The power business posted an operating EBITDA of ₹346 Crore. This came in 20.80% y-o-y lower against ₹437.20 Crore in the ...

The pharma business said that its revenue from operations slipped as much as 12.50% to ₹7,906 Crore in Q1FY26.

Britannia Industries Ltd registered a 3% year-on-year (YoY) growth in its net profit for the quarter ended June 2025 at ₹520 ...

At the operating level, EBITDA rose to ₹350 crore, higher than ₹321.5 crore a year ago. However, margins stayed flat at 23.4% ...

Jindal Saw's EBITDA dropped 20.2% year-on-year to ₹670 crore. EBITDA margin narrowed to 16.4% from 17% last year.

The contract, estimated at around ₹282 crore, is expected to strengthen the company’s position in India’s defence mobility ...

The 3-day RBI MPC meet commenced on August 04, 2025 and will culminate in the announcement of the RBI Monetary Policy on ...

One 97 Communications announced a net profit of ₹122.50 Crore for the first time since listing, supported by higher income.

Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated net profit of ₹824.20 Crore in the quarter under review, down by 10.20% on ...

The BSNL deal is service-based and has a delivery deadline of July 31, 2028, the company said in a regulatory update. On the financial side, RailTel posted a net profit of ₹66 crore for the June ...

Prior to the current release, credit growth had moderated and raised concerns over whether the RBI’s jumbo 50bps rate cut was ...

NIFTY PHARMA index recorded a loss of 2.87% for the week. Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories and Divi’s ...